ArticleCureus2024
Investigating the Clinico-Etiological Profile of Pediatric Pancytopenia: A Prospective Study in a Tertiary Care Center.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background A decrease in red blood cells, white blood cells, and platelets is known as pancytopenia, and it is frequently caused by a variety of illnesses such as bone marrow failure, malnutrition, infections, autoimmune diseases, or blood malignancies. The purpose of this study was to investigate the hematological, clinical, and causative aspects of pancytopenia in children ranging in age from one month to 18 years. Methodology At the Department of Pediatrics, a 12-month prospective observational research involving 70 pediatric patients with pancytopenia was carried out. Documentation included demographic information, clinical manifestations, history of vaccinations, and particular disease features. The study evaluated the frequency of several reasons (autoimmune, neoplastic, nutritional, infectious, and others) that lead to pancytopenia. Results The mean age of the 70 patients was 5.08 ± 3.22 years, comprising 30 males (42.86%) and 40 females (57.14%). Fever (50 cases, 71.43%), arthralgias (39 cases, 55.71%), weight loss (11 cases, 15.71%), and failure to thrive (13 cases, 18.57%) were among the most common symptoms. Examinations of the bone marrow revealed that 29 patients (41.43%) had aplastic alterations, 20 patients (28.57%) had hyperplastic abnormalities, and 21 patients (30%) had normal cellularity. Fourteen patients (20%) had nutritional reasons, mostly megaloblastic anemia, and six patients (8.57%) suffering from neoplastic disorders had acute lymphoblastic leukemia (ALL). Hemolytic anemia, parvovirus B19, miliary tuberculosis (TB), aplastic anemia, and systemic lupus erythematosus were among the other noteworthy etiologies. Conclusion Many cases of pediatric pancytopenia in the region are preventable. Greater awareness and appropriate diagnostic strategies are crucial for the early identification and management of these conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.